Sign in

Research summary ·

A multiancestry polygenic risk score improves stratification in patients with hypertrophic cardiomyopathy.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This study built a polygenic risk score for hypertrophic cardiomyopathy, or HCM. HCM has long been seen as a disease driven by single gene variants. These variants explain only some cases, so other genes may add to it. Earlier scores came mostly from European-ancestry groups. The new score used data from BioBank Japan and other cohorts of mixed ancestry. The team tested it in a multiancestry group in the USA.

What they found

People in the highest score quintile had a 2.11-fold higher risk of HCM. Among carriers of single gene variants, the risk was nearly 70-fold higher. The score improved risk sorting. It also showed trends toward better prediction by ancestry. In people with HCM, a higher score went with worse heart and vessel outcomes.

What it means for patients

The authors say these findings support adding multiancestry scores to HCM risk assessment and prognosis.

Why it is not certain yet

The abstract calls the ancestry-specific gains trends. It does not say how many people were tested. The score was tested in one USA-based group. A risk score shows links, not cause.

Source

A multiancestry polygenic risk score improves stratification in patients with hypertrophic cardiomyopathy.

PubMed · PMID 42680905

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Hypertrophic cardiomyopathy publications